Product Reports Resources Pricing Login Book a demo

Iterative Health

Health Tech & Medtech · Boston, United States · Founded 2017

Iterative Scopes is a startup that operates in the healthcare sector, specifically focusing on Gastrointestinal (GI) care. The company leverages the power of artificial intelligence (AI) and machine learning (ML) to enhance the precision and effectiveness of GI treatments. Its primary aim is to provide world-class care and treatment to patients globally, with a particular focus on colorectal cancer prevention and diagnosis. The company's business model revolves around the development and deployment of AI and ML technologies in the healthcare sector. One of their key products is SKOUT®, an FDA cleared polyp detection device that aids physicians in detecting adenomas, a precursor to colorectal cancer. This device does not replace physician judgment but enhances it, leading to more accurate diagnoses. Iterative Scopes also offers services and technology that optimize clinical trials, maximizing the value of clinical research practices. This is achieved through their AI-enabled documentation technology, which improves the quality and continuity of patient care. The technology also allows for standardized, high-quality reporting across institutions, making high-standard care accessible to previously underserved populations. The company's revenue is likely generated through the sale of their AI and ML technologies and services to healthcare institutions and professionals. They also potentially earn from partnerships with research institutions and pharmaceutical companies for clinical trial optimization. Keywords: Healthcare, Gastrointestinal Care, Artificial Intelligence, Machine Learning, Colorectal Cancer, Clinical Trial Optimization, SKOUT®, Adenoma Detection, AI-Enabled Documentation, Underserved Populations.

Investors

18 investors on Iterative Health's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Wavemaker Partners
Tau Ventures
P5 Health Ventures
Series A 11 investors entered at this stage
Plug and Play
Obvious Ventures
Lee Shapiro
Eli Lilly
Nat Turner
Zach Weinberg
Johnson & Johnson Innovation
Breyer Capital
Seae Ventures
Insight Partners
Clearlake Capital Group
Series B+ 4 investors entered at this stage
Insight Partners
Plug and Play
Clearlake Capital Group
Massachusetts Institute of Technology

Global footprint

Where Iterative Health has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States96.8%
🇵🇭 Philippines1.6%
🇵🇱 Poland0.8%
🇩🇪 Germany0.8%
4 countries shown
Web traffic by country
6.9K monthly visits
across markets
🇺🇸 United States84.1%
🇮🇳 India11.6%
🇨🇦 Canada2.9%
🇵🇰 Pakistan1.4%
Top 4 markets shown

Talent graph

The shape of Iterative Health's talent

Dealroom maps Iterative Health's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

24 team members profilednamed & role-tagged by Dealroom
193 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Iterative Health's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$854k patent portfolio · 6 active families

Estimated portfolio value
$854k
0.06% of valuation · 251.7× smaller than top peer Butterfly Network ($215M)
6 active patent families
Where Iterative Health innovates Autoimmune inflammatory bowel diseaseBowels diseasesComputer visionEndoscopyGastroenterology

Where Iterative Health concentrates vs peers

Each axis is a top-10 topic across Iterative Health and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Iterative Health

An AI-synthesized read of the highest-engagement posts about Iterative Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Iterative Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.